Y. Stepanishyna

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.

G. Salles, S. Montoto, H. Holte, 2021, European journal of cancer.

Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma

F. Angrilli, M. Federico, F. Merli, 2020, British journal of haematology.

PET/CT Imaging of Lymphoma Outside the Western World

S. Chauvie, F. Bergesio, Mubarak M. Al-Mansour, 2021, Lymphoma.

P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REPORT FROM THE PROSPECTIVE INTERNATIONAL T-CELL LYMPHOMA PROJECT

S. Montoto, S. Pileri, M. Federico, 2022, Hematological oncology.

Characteristics and clinical outcomes of patients with ALK‐positive anaplastic large cell lymphoma: Report from the prospective international T‐cell lymphoma project

S. Montoto, S. Pileri, M. Federico, 2022, Hematological oncology.

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification

M. Federico, M. Manni, T. Skrypets, 2022, Hematological oncology.

Comparison of the efficiency of peripheral blood stem cell apheresis on the blood cell separators.

Y. Stepanishyna, Kateryna Filonenko, Veronika Zarutska, 2022, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.